Mitsubishi UFJ Trust & Banking
NVCR icon

Mitsubishi UFJ Trust & Banking’s NovoCure NVCR Stock Holding History

Mitsubishi UFJ Trust & Banking’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-110,261
Closed -$1.72M – 1127
2024
Q1 		$1.72M Sell
110,261
-31,400
-22% -$462K ﹤0.01% 794
2023
Q4 		$2.11M Sell
141,661
-10,230
-7% -$137K 0.01% 777
2023
Q3 		$2.45M Sell
151,891
-59,358
-28% -$1.71M 0.01% 767
2023
Q2 		$8.77M Sell
211,249
-10,191
-5% -$633K 0.02% 575
2023
Q1 		$13.3M Sell
221,440
-18,294
-8% -$1.46M 0.03% 484
2022
Q4 		$17.6M Sell
239,734
-162,861
-40% -$12.3M 0.05% 413
2022
Q3 		$30.6M Sell
402,595
-3,703
-0.9% -$289K 0.09% 250
2022
Q2 		$28.2M Buy
406,298
+1,899
+0.5% +$143K 0.07% 281
2022
Q1 		$33.5M Sell
404,399
-1,274
-0.3% -$93.8K 0.08% 258
2021
Q4 		$30.5M Sell
405,673
-8,870
-2% -$890K 0.06% 320
2021
Q3 		$48.2M Sell
414,543
-8,554
-2% -$1.29M 0.1% 223
2021
Q2 		$93.9M Sell
423,097
-136,918
-24% -$26.6M 0.2% 130
2021
Q1 		$74M Sell
560,015
-17,671
-3% -$2.8M 0.16% 151
2020
Q4 		$100M Buy
577,686
+43,656
+8% +$5.97M 0.2% 125
2020
Q3 		$59.4M Sell
534,030
-18,470
-3% -$1.48M 0.13% 182
2020
Q2 		$32.8M Sell
552,500
-4,070
-0.7% -$268K 0.08% 272
2020
Q1 		$37.5M Sell
556,570
-68,469
-11% -$5.41M 0.11% 217
2019
Q4 		$52.7M Sell
625,039
-241,311
-28% -$19.5M 0.13% 179
2019
Q3 		$64.8M Sell
866,350
-159,610
-16% -$12.8M 0.17% 139
2019
Q2 		$64.9M Sell
1,025,960
-51,220
-5% -$2.6M 0.22% 96
2019
Q1 		$51.9M Buy
1,077,180
+342,161
+47% +$16.5M 0.19% 118
2018
Q4 		$24.6M Sell
735,019
-74,882
-9% -$2.74M 0.1% 236
2018
Q3 		$42.4M Sell
809,901
-6,119
-0.7% -$244K 0.15% 163
2018
Q2 		$25.5M Sell
816,020
-34,890
-4% -$971K 0.04% 458
2018
Q1 		$18.6M Buy
+850,910
New +$18.3M 0.03% 551

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Mitsubishi UFJ Trust & Banking's NVCR Position: Q2 2024 in Review

Mitsubishi UFJ Trust & Banking sold out of NovoCure (NVCR) in Q2 2024, closing a stake of 110,261 shares — an estimated $1.72M sold.

Mitsubishi UFJ Trust & Banking first reported a position in NVCR in Q1 2018 and held it in 25 quarters. The position peaked at $100M in Q4 2020. 236 funds tracked by Wall St. Rank hold NVCR as of Q2 2024.

  • Mitsubishi UFJ Trust & Banking reported no remaining NovoCure position as of Q2 2024 after selling out during the quarter.
  • Mitsubishi UFJ Trust & Banking sold 110,261 NovoCure shares in Q2 2024, an estimated $1.72M.
  • Mitsubishi UFJ Trust & Banking first reported a position in NovoCure in Q1 2018 and held it in 25 quarters.
  • Mitsubishi UFJ Trust & Banking's NovoCure position peaked at $100M in Q4 2020.
  • 236 funds tracked by Wall St. Rank held NovoCure as of Q2 2024.

Based on Mitsubishi UFJ Trust & Banking's 13F filing for Q2 2024, filed 8 Aug 2024.